Cargando…
Benefits of near-universal vaccination and treatment access to manage COVID-19 burden in the United States
BACKGROUND: As we continue the fourth year of the COVID-19 epidemic, SARS-CoV-2 infections still cause high morbidity and mortality in the United States. During 2020–2022, COVID-19 was one of the leading causes of death in the United States and by far the leading cause among infectious diseases. Vac...
Autores principales: | Yang, Fuhan, Tran, Thu Nguyen-Anh, Howerton, Emily, Boni, Maciej F., Servadio, Joseph L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463609/ https://www.ncbi.nlm.nih.gov/pubmed/37620926 http://dx.doi.org/10.1186/s12916-023-03025-z |
Ejemplares similares
-
Benefits of near-universal vaccination and treatment access to manage COVID-19 burden in the United States
por: Yang, Fuhan, et al.
Publicado: (2023) -
Role of Seasonal Importation and Random Genetic Drift on Selection for Drug-Resistant Genotypes of Plasmodium falciparum in High Transmission Settings
por: Zupko, Robert J., et al.
Publicado: (2023) -
Optimal SARS-CoV-2 vaccine allocation using real-time seroprevalence estimates in Rhode Island and Massachusetts
por: Tran, Thu Nguyen-Anh, et al.
Publicado: (2021) -
Optimal SARS-CoV-2 vaccine allocation using real-time attack-rate estimates in Rhode Island and Massachusetts
por: Tran, Thu Nguyen-Anh, et al.
Publicado: (2021) -
SARS-CoV-2 epidemic after social and economic reopening in three US states reveals shifts in age structure and clinical characteristics
por: Wikle, Nathan, et al.
Publicado: (2021)